International Clinical Trial: A study looking at using two drugs as dual anti-HIV therapy in people who have previously had brain injury caused by HIV

Geneva, May 16 -- International Clinical Trials Registry received information related to the study (ISRCTN47418801) titled 'A study looking at using two drugs as dual anti-HIV therapy in people who have previously had brain injury caused by HIV' on May 12 2025.

Study Type: Interventional

Study Design: Non-randomized single-arm study (Safety, Efficacy)

Primary Sponsor: Imperial College London

Condition: HIV infection Infections and Infestations

Intervention: This is a non-randomised, single-arm study. Dovato 50 mg/300 mg will be given to all participants who are enrolled into the study. Participants will take daily oral Dovato from baseline for the 2-year study duration.

Recruitment Status: Recruiting

Phase: Phase IV

Date of ...